In this manner, miR‐126 holds promise as a prognostic marker for ESCC and proposes the involvement of a novel ‘DNMT1‐miR‐126 epigenetic circuit’ in the progression of ESCC [133]. This evidence concerns the gene DNMT1 and esophageal squamous cell carcinoma.